uPAR: a versatile signalling orchestrator

F Blasi, P Carmeliet - Nature reviews Molecular cell biology, 2002 - nature.com
The plasminogen system has been implicated in clot lysis, wound healing, tissue
regeneration, cancer and many other processes that affect health and disease. The …

suPAR: the molecular crystal ball

M Thunø, B Macho, J Eugen-Olsen - Disease markers, 2009 - Wiley Online Library
soluble urokinase Plasminogen Activator Receptor (suPAR) levels reflect inflammation and
elevated suPAR levels are found in several infectious diseases and cancer. suPAR exists in …

MicroRNA: biogenesis, function and role in cancer

LA MacFarlane, PR Murphy - Current genomics, 2010 - ingentaconnect.com
MicroRNAs are small, highly conserved non-coding RNA molecules involved in the
regulation of gene expression. MicroRNAs are transcribed by RNA polymerases II and III …

[HTML][HTML] MicroRNA-21 targets tumor suppressor genes in invasion and metastasis

S Zhu, H Wu, F Wu, D Nie, S Sheng, YY Mo - Cell research, 2008 - nature.com
MicroRNAs (miRNAs) are a class of naturally occurring small non-coding RNAs that target
protein-coding mRNAs at the post-transcriptional level. Our previous studies suggest that mir …

[HTML][HTML] Plasmin and plasminogen system in the tumor microenvironment: implications for cancer diagnosis, prognosis, and therapy

AG Bharadwaj, RW Holloway, VA Miller, DM Waisman - Cancers, 2021 - mdpi.com
Simple Summary In this review, we present a detailed discussion of how the plasminogen-
activation system is utilized by tumor cells in their unrelenting attack on the tissues …

[HTML][HTML] Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review

Y Backes, KF van der Sluijs, DP Mackie, F Tacke… - Intensive care …, 2012 - Springer
Purpose Systemic levels of soluble urokinase-type plasminogen activator receptor (suPAR)
positively correlate with the activation level of the immune system. We reviewed the …

The urokinase system of plasminogen activation and prognosis in 2780 breast cancer patients

JA Foekens, HA Peters, MP Look, H Portengen… - Cancer research, 2000 - AACR
The antigen levels of components of the urokinase-type plasminogen activator (uPA) system
of plasminogen activation are correlated with prognosis in several types of cancers …

Evolving role of uPA/uPAR system in human cancers

K Dass, A Ahmad, AS Azmi, SH Sarkar… - Cancer treatment …, 2008 - Elsevier
Recent advancements in cancer research have led to some major breakthroughs; however,
the impact on overall cancer-related death rate remains unacceptable, suggesting that …

The urokinase plasminogen activator system: role in malignancy

MJ Duffy - Current pharmaceutical design, 2004 - ingentaconnect.com
The urokinase plasminogen activator (uPA) system consists of the serine protease uPA, its
glycolipid-anchored receptor, uPAR and its 2 serpin inhibitors, plasminogen activator …

The urokinase plasminogen activator system: a target for anti-cancer therapy

S Ulisse, E Baldini, S Sorrenti… - Current cancer drug …, 2009 - ingentaconnect.com
The urokinase plasminogen activator (uPA) system (uPAS) consists of the uPA, its cognate
receptor (uPAR) and two specific inhibitors, the plasminogen activator inhibitor 1 (PAI-1) and …